Picard Medical, Inc. (PMI)
NYSEAMERICAN: PMI · Real-Time Price · USD
6.46
-0.20 (-3.00%)
At close: Sep 9, 2025, 4:00 PM
6.35
-0.11 (-1.70%)
After-hours: Sep 9, 2025, 8:00 PM EDT
Company Description
Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products.
The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure.
The company operates in the USA, Europe, and internationally. The company was incorporated in 2021 and is based in Tucson, Arizona.
Picard Medical, Inc. is a subsidiary of Hunniwell Picard I, Llc.
Picard Medical, Inc.
Country | United States |
Founded | 1981 |
IPO Date | Aug 29, 2025 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 75 |
CEO | Patrick Schnegelsberg |
Contact Details
Address: 1992 E Silverlake Road Tucson, Arizona 85713 United States | |
Phone | 520 545 1234 |
Website | syncardia.com |
Stock Details
Ticker Symbol | PMI |
Exchange | NYSEAMERICAN |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $4.00 |
CIK Code | 0002030617 |
CUSIP Number | 740459102 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Patrick NJ Schnegelsberg | Chief Executive Officer and Director |
Bernard Skaggs | Chief Financial Officer |
Matt Schuster | Chief Operating Officer |
Richard Fang | Director |
Daniel Teo | Director |
Chris Hsieh | Director |
Richard G. Smith | Scientific Advisor, SynCardia |
Frank Tinker | Chief Technology Officer, SynCardia |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Sep 4, 2025 | 8-K | Current Report |
Sep 2, 2025 | 424B4 | Prospectus |
Aug 28, 2025 | CERT | Certification by an exchange approving securities for listing |
Aug 12, 2025 | EFFECT | Notice of Effectiveness |
Aug 11, 2025 | 8-A12B | Registration of securities |
Aug 6, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Jul 30, 2025 | FWP | Free Writing Prospectus |
Jul 30, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Jul 18, 2025 | FWP | Free Writing Prospectus |
Jul 18, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |